Shanghai Fosun Pharmaceutical Group Co Eulerpool News

Shanghai Fosun Pharmaceutical Group Co Eulerpool News

Shanghai Fosun Pharmaceutical Group Co Stock News

Shanghai Fosun Pharmaceutical Group Co is being monitored by journalists and investors worldwide. We gather the latest Shanghai Fosun Pharmaceutical Group Co news here.

• August 28 ·

  Yahoo
  Fosun Pharma Announces 2024 Interim Results
• April 26 ·

  Yahoo
  Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
• March 8 ·

  SeekingAlpha
  Fosun Tourism At Crossroads As Parent Shops Its Two Major Assets
• December 17 ·

  SeekingAlpha
  Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4B Deal
• December 15 ·

  Yahoo
  Fosun’s Hospital Arm Weighs $141 Million Funding Round, Sources Say
• December 14 ·

  Yahoo
  Fosun Pharma's Global Multi-Center Phase III Clinical Trial Project for A New Antimalarial Drug Receives 500 Million Japanese Yen Investment from GHIT Fund to Jointly Improve the Global Accessibility of Antimalarial Drugs
• November 12 ·

  Yahoo
  Fosun Pharma prepares to deliver Da Vinci surgical robots to make advanced medical treatment affordable to Chinese patients
• September 20 ·

  Yahoo
  Cevira Phase III trial for non-surgical HSIL treatment meets primary endpoint
• September 7 ·

  SeekingAlpha
  Debt Pressures Cast Cloud Over Fosun Pharma Results
• August 30 ·

  Yahoo
  Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure